ClinicalTrials.gg

Program

Antioxidants

Also written as “Antioxidants + Clomiphene Citrate”, “Antioxidants + FSH” and “Antioxidants Alone”.

Its studies are mostly in Oligospermia · Infertility, Male, led by 2 companies.

Furthest: phase 4, since Feb 26, 20183 company-led studies, 1 open or runningNext primary completion: Oct 15, 2027 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Hamad Medical21 open or runningphase 4since Feb 26, 2018Feb 26, 2018Oct 15, 2027phase 4 · NCT07862725
Vitrolife10 open or runningno phasesince Dec 16, 2016Dec 16, 2016none ahead

Also a collaborator on its studies: fairhaven-health.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 16, 2016First study: no phase study in Culture MediaNew to VitrolifeVitrolife · NCT02999958 · 128 enrolled · Japan
  2. Feb 26, 2018Hamad Medical's first study: phase 4 study in Infertility, MaleNew to Hamad MedicalHamad Medical · NCT03464656 · 100 enrolled · Qatar
  3. Sep 29, 2026Phase 4 study in OligospermiaHamad Medical · NCT07862725 · 360 planned · Qatar

Ahead

  1. Oct 15, 2027Primary completion: phase 4 study in OligospermiaHamad Medical · NCT07862725

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07862725Oligospermia · Qatar4Not yet recruitingHamad MedicalOct 15, 2027360
NCT03464656Infertility, Male · Qatar4UNKNOWNHamad MedicalJul 1, 2018100
NCT02999958Culture Media · Japan–CompletedVitrolifeMay 2018128

How it is read

Names in the registry

  • “Antioxidants + Clomiphene Citrate”, 1 entry
  • “Antioxidants + FSH”, 1 entry
  • “Antioxidants Alone”, 1 entry
  • “Antioxidants”, 1 entry
  • “Fairhaven Pro for men”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.